Literature DB >> 17171358

Quantification of adenosine A2A receptors in the human brain using [11C]TMSX and positron emission tomography.

Mika Naganawa1,2, Yuichi Kimura3, Masahiro Mishina4, Yoshitsugu Manabe5, Kunihiro Chihara5, Keiichi Oda1, Kenji Ishii1, Kiichi Ishiwata1.   

Abstract

PURPOSE: [7-methyl-(11)C]-(E)-8-(3,4,5-trimethoxystyryl)-1,3,7-trimethylxanthine ([(11)C]TMSX) is a positron-emitting adenosine A(2A) receptor (A2AR) antagonist for visualisation of A2AR distribution by positron emission tomography (PET). The aims of this paper were to use a kinetic model to analyse the behaviour of [(11)C]TMSX in the brain and to examine the applicability of the Logan plot. We also studied the applicability of a simplified Logan plot by omitting metabolite correction and arterial blood sampling.
METHODS: The centrum semiovale was used as a reference region on the basis of a post-mortem study showing that it has a negligibly low density of A2ARs. Compartmental analysis was performed in five normal subjects. Parametric images of A2AR binding potential (BP) were also generated using a Logan plot with or without metabolite correction and with or without arterial blood sampling. To omit arterial blood sampling, we applied a method to extract the plasma-related information using independent component analysis (EPICA).
RESULTS: The estimated K (1)/k (2) was confirmed to be common in the centrum semiovale and main cortices. The three-compartment model was well fitted to the other regions using the fixed value of K (1)/k (2) estimated from the centrum semiovale. The estimated BPs using the Logan plot matched those derived from compartment analysis. Without the metabolite correction, the estimate of BP underestimated the true value by 5%. The estimated BPs agreed regardless of arterial blood sampling.
CONCLUSION: A three-compartment model with a reference region, the centrum semiovale, describes the kinetic behaviour of [(11)C]TMSX PET images. A2ARs in the human brain can be visualised as a BP image using [(11)C]TMSX PET without arterial blood sampling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17171358     DOI: 10.1007/s00259-006-0294-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  24 in total

1.  11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligand.

Authors:  K Ishiwata; J Noguchi; S Wakabayashi; J Shimada; N Ogi; T Nariai; A Tanaka; K Endo; F Suzuki; M Senda
Journal:  J Nucl Med       Date:  2000-02       Impact factor: 10.057

2.  Further characterization of a CNS adenosine A2a receptor ligand [11C]KF18446 with in vitro autoradiography and in vivo tissue uptake.

Authors:  K Ishiwata; N Ogi; J Shimada; H Nonaka; A Tanaka; F Suzuki; M Senda
Journal:  Ann Nucl Med       Date:  2000-04       Impact factor: 2.668

3.  Potential of [11C]TMSX for the evaluation of adenosine A2A receptors in the skeletal muscle by positron emission tomography.

Authors:  Kiichi Ishiwata; Masaki Mizuno; Yuichi Kimura; Kazunori Kawamura; Keiichi Oda; Toru Sasaki; Yoshio Nakamura; Isao Muraoka; Kenji Ishii
Journal:  Nucl Med Biol       Date:  2004-10       Impact factor: 2.408

4.  Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studies.

Authors:  Marc A Kropholler; Ronald Boellaard; Alie Schuitemaker; Bart N M van Berckel; Gert Luurtsema; Albert D Windhorst; Adriaan A Lammertsma
Journal:  J Cereb Blood Flow Metab       Date:  2005-07       Impact factor: 6.200

5.  Omission of serial arterial blood sampling in neuroreceptor imaging with independent component analysis.

Authors:  Mika Naganawa; Yuichi Kimura; Tadashi Nariai; Kenji Ishii; Keiichi Oda; Yoshitsugu Manabe; Kunihiro Chihara; Kiichi Ishiwata
Journal:  Neuroimage       Date:  2005-04-01       Impact factor: 6.556

6.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

7.  Preclinical studies on [11C]TMSX for mapping adenosine A2A receptors by positron emission tomography.

Authors:  Kiichi Ishiwata; Wei-Fang Wang; Yuichi Kimura; Kazunori Kawamura; Kenji Ishii
Journal:  Ann Nucl Med       Date:  2003-05       Impact factor: 2.668

Review 8.  Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities.

Authors:  Bertil B Fredholm; Per Svenningsson
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

9.  Potential of an adenosine A2A receptor antagonist [11C]TMSX for myocardial imaging by positron emission tomography: a first human study.

Authors:  Kiichi Ishiwata; Kazunori Kawamura; Yuichi Kimura; Keiichi Oda; Kenji Ishii
Journal:  Ann Nucl Med       Date:  2003-09       Impact factor: 2.668

10.  First visualization of adenosine A(2A) receptors in the human brain by positron emission tomography with [11C]TMSX.

Authors:  Kiichi Ishiwata; Masahiro Mishina; Yuichi Kimura; Keiichi Oda; Toru Sasaki; Kenji Ishii
Journal:  Synapse       Date:  2005-02       Impact factor: 2.562

View more
  10 in total

1.  In vivo evaluation of [11C]preladenant positron emission tomography for quantification of adenosine A2A receptors in the rat brain.

Authors:  Xiaoyun Zhou; Shivashankar Khanapur; Johan R de Jong; Antoon Tm Willemsen; Rudi Ajo Dierckx; Philip H Elsinga; Erik Fj de Vries
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

2.  Automated reference region extraction and population-based input function for brain [(11)C]TMSX PET image analyses.

Authors:  Eero Rissanen; Jouni Tuisku; Pauliina Luoto; Eveliina Arponen; Jarkko Johansson; Vesa Oikonen; Riitta Parkkola; Laura Airas; Juha O Rinne
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-05       Impact factor: 6.200

3.  Adenosine A2A receptor availability in patients with early- and moderate-stage Parkinson's disease.

Authors:  Imran Waggan; Eero Rissanen; Jouni Tuisku; Juho Joutsa; Semi Helin; Riitta Parkkola; Juha O Rinne; Laura Airas
Journal:  J Neurol       Date:  2022-09-02       Impact factor: 6.682

4.  Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.

Authors:  Eero Rissanen; Jere R Virta; Teemu Paavilainen; Jouni Tuisku; Semi Helin; Pauliina Luoto; Riitta Parkkola; Juha O Rinne; Laura Airas
Journal:  J Cereb Blood Flow Metab       Date:  2013-05-22       Impact factor: 6.200

5.  Test-retest variability of adenosine A2A binding in the human brain with (11)C-TMSX and PET.

Authors:  Mika Naganawa; Masahiro Mishina; Muneyuki Sakata; Keiichi Oda; Mikio Hiura; Kenji Ishii; Kiichi Ishiwata
Journal:  EJNMMI Res       Date:  2014-12-29       Impact factor: 3.138

Review 6.  Tracers for non-invasive radionuclide imaging of immune checkpoint expression in cancer.

Authors:  Peter Wierstra; Gerwin Sandker; Erik Aarntzen; Martin Gotthardt; Gosse Adema; Johan Bussink; René Raavé; Sandra Heskamp
Journal:  EJNMMI Radiopharm Chem       Date:  2019-11-06

Review 7.  Allosteric Interactions between Adenosine A2A and Dopamine D2 Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging.

Authors:  Kavya Prasad; Erik F J de Vries; Philip H Elsinga; Rudi A J O Dierckx; Aren van Waarde
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923

8.  Non-Invasive Assessment of Locally Overexpressed Human Adenosine 2A Receptors in the Heart of Transgenic Mice.

Authors:  Daniel Gündel; Thu Hang Lai; Sladjana Dukic-Stefanovic; Rodrigo Teodoro; Winnie Deuther-Conrad; Magali Toussaint; Klaus Kopka; Rareş-Petru Moldovan; Peter Boknik; Britt Hofmann; Ulrich Gergs; Joachim Neumann; Peter Brust
Journal:  Int J Mol Sci       Date:  2022-01-18       Impact factor: 5.923

9.  Adenosine A2A receptor in schizophrenia: an in vivo brain PET imaging study.

Authors:  Tiago Reis Marques; Sridhar Natesan; Eugenii A Rabiner; Graham E Searle; Roger Gunn; Oliver D Howes; Shitij Kapur
Journal:  Psychopharmacology (Berl)       Date:  2021-06-26       Impact factor: 4.415

Review 10.  In Vivo PET Imaging of Adenosine 2A Receptors in Neuroinflammatory and Neurodegenerative Disease.

Authors:  Anna Vuorimaa; Eero Rissanen; Laura Airas
Journal:  Contrast Media Mol Imaging       Date:  2017-11-20       Impact factor: 3.161

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.